Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
17 January 2019 | Story Mamosa Makaya | Photo Xolisa Mnukwa
Nkahiseng
Nkahiseng Ralepeli will join the Rhodes Scholarship cohort of 2019.

Aspiring lawyer and political prodigy, Nkahiseng Ralepeli, will soon join a cohort of Rhodes Scholarship recipients at the University of Oxford in the UK later this year. He completed his LLB at the University of the Free State (UFS) in 2018, and it comes as no surprise that this young achiever has his eyes set on greater heights.

As a student, Nkahiseng was always a cut above the rest, with his involvement in non-governmental organisations such as Corruption Watch and Debate Afrika, where he used debating to not only educate youth in South Africa but to engage various social ills that plague the country in whichever way he could. He represented the UFS at various debating tournaments such as the Pan-African Universities Debating Championships and the World Universities Debating Championships.

“This is something I’ve wanted for an incredibly long time. Receiving this scholarship is so important, and makes me feel that all my efforts and work have been validated. What I’ve learned is that regardless of the situation you’re born into, rich or poor, hard work is rewarded. I hope this experience will help me realise my dreams and career goals, but most importantly I want to have a significant impact in whatever space I find myself in and on the people I encounter,” said Nkahiseng.

As an Abe Bailey Bursary recipient, he is deeply interested in the transformation of African political theory and the establishment of various structures in the development and maintenance of African ‘infant’ democracies and post-civil wars. He later hopes to pursue a career in South African politics. His list of achievements keeps getting longer as he adds to it the Rhodes Scholarship. The UFS is truly proud to have an alumnus of this high calibre.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept